Fluoride

Fluoride

SCHEMBL4839185

F.F.[Tl]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL11662669 1.00
Fluoride SCHEMBL228822 1.00
Fluoride SCHEMBL8928596 1.00
Fluoride SCHEMBL4190313 1.00
Fluoride SCHEMBL38465 0.71
Fluoride SCHEMBL49263 0.71
Fluoride SCHEMBL9318976 0.71
Methane SCHEMBL20506644 0.71
F-18 SCHEMBL117749 0.71
Fluoride Ion F-18 SCHEMBL12714265 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080193380-A1 Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy DALTON JAMES T 2008-08-14 US claimed
US-20040052727-A1 Radiolableled selective androgen receptor modulators andtheir use in prostate cancer imaging and therapy UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2004-03-18 US claimed
WO-2003074450-A2 RADIOLABELED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND THEIR USE IN PROSTATE CANCER IMAGING AND THERAPY THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 2003-09-12 WO claimed
US-20020098148-A1 NON-STEROIDAL RADIOLABELED AGONIST/ANTAGONIST COMPOUNDS AND THEIR USE IN PROSTATE CANCER IMAGING MILLER DUANE D (US) 2002-07-25 US claimed
US-6019957-A Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 2000-02-01 US claimed
WO-1998055153-A9 NON-STEROIDAL RADIOLABELED AGONIST/ANTAGONIST COMPOUNDS AND THEIR USE IN PROSTATE CANCER IMAGING UNIV TENNESSEE RES CORP (US) 1999-04-01 WO claimed
WO-1998055153-A1 NON-STEROIDAL RADIOLABELED AGONIST/ANTAGONIST COMPOUNDS AND THEIR USE IN PROSTATE CANCER IMAGING THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 1998-12-10 WO claimed
US-20080193380-A1 Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy DALTON JAMES T 2008-08-14 US disclosed
US-7344700-B2 Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 2008-03-18 US disclosed
US-20040052727-A1 Radiolableled selective androgen receptor modulators andtheir use in prostate cancer imaging and therapy UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2004-03-18 US disclosed
WO-2003074450-A2 RADIOLABELED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND THEIR USE IN PROSTATE CANCER IMAGING AND THERAPY THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 2003-09-12 WO disclosed
US-20020098148-A1 NON-STEROIDAL RADIOLABELED AGONIST/ANTAGONIST COMPOUNDS AND THEIR USE IN PROSTATE CANCER IMAGING MILLER DUANE D (US) 2002-07-25 US disclosed
US-6019957-A Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 2000-02-01 US disclosed
WO-1998055153-A9 NON-STEROIDAL RADIOLABELED AGONIST/ANTAGONIST COMPOUNDS AND THEIR USE IN PROSTATE CANCER IMAGING UNIV TENNESSEE RES CORP (US) 1999-04-01 WO disclosed
WO-1998055153-A1 NON-STEROIDAL RADIOLABELED AGONIST/ANTAGONIST COMPOUNDS AND THEIR USE IN PROSTATE CANCER IMAGING THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 1998-12-10 WO disclosed